AHA scientific statement: Lp(a) as a genetically determined, causal and prevalent risk factor (2022)

Reyes-Soffer, Ginsberg, Berglund and colleagues, ATVB 2022: the biology, pathophysiology and clinical evidence, and the gaps in assay standardisation, testing guidance and therapy that the 2024 to 2026 documents began to close.